Clinical Trials

Keywords/SWOG Study Number

Area of Research

Accrual Status

Any

Open

Closed

Limit to SWOG Trials

All Trials

SWOG Trials Only

Show only published studies

Study Type

Treatment

Study Chair

Participating Institution

Phase

Cancer Control Subcommittee

Study Sponsor

FDA Registration Trial

Uses PRO Forms

1032 Results

View

Closed

Phase

Accrual

70%

Published

SWOG Clinical Trial Number

SWOG-9107

A Phase II Pilot Study of High Dose 24-Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA for Patients with Colorectal Cancer

Activated

01-01-1993

Closed

08-01-1994

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9140

Phase II Study of Oral Bropirimine Combined with Intravesical Bacillus Calmette - Guerin (Tice) in Patients with Carcinoma in Situ of the Bladder

Research Committee(s)

Genitourinary Cancer

Activated

12-01-1992

Closed

12-01-1997

Closed

Phase

Accrual

15%

SWOG Clinical Trial Number

SWOG-9101

Evaluation of Edatrexate in Patients with Advanced or Recurrent Bladder Carcinoma, Phase II

Activated

11-15-1992

Closed

11-15-1993

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9003

Fludarabine for Waldenstrom's Macroglobulinemia (WM): A Phase II Pilot Study for Untreated and Previously Treated Patients

Research Committee(s)

Myeloma

Activated

11-01-1992

Closed

09-01-1998

Closed

Phase

SWOG Clinical Trial Number

SWOG-9205

Central Prostate Cancer Serum Repository Protocol

Research Committee(s)

Genitourinary Cancer

Activated

10-01-1992

Closed

10-01-2006

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-9225

Pharmacokinetics of Isotretinoin or All Trans Retinoic Acid: An Ancillary Study to SWOG-9132

Research Committee(s)

Gynecologic Cancer

Activated

09-15-1992

Closed

06-01-1996

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9132

Evaluation of Alpha Interferon/Isotretinoin or Alpha Interferon/All Trans Retinoic Acid in Cervical Cancer, Phase II

Research Committee(s)

Gynecologic Cancer

Activated

09-15-1992

Closed

05-15-1996

Closed

Phase

Accrual

75%

Published

SWOG Clinical Trial Number

SWOG-9133

Randomized Trial of Subtotal Nodal Irradiation Versus Doxorubicin Plus Vinblastine and Subtotal Nodal Irradiation for Stage I-IIA Hodgkin's Disease, Phase III

Research Committee(s)

Lymphoma

Activated

09-15-1992

Closed

04-24-2000

Closed

Phase

Accrual

SWOG Clinical Trial Number

SWOG-9130

Smoking Cessation for Early Stage Bladder Cancer Patients Using A Combined Brief Physician-Message and Cancer Information Service (CIS) Counseling Approach

Activated

09-01-1992

Closed

08-17-1995

Closed

Phase

Accrual

65%

Published

SWOG Clinical Trial Number

SWOG-9104

Evaluation of Doxorubicin/Vinblastine Combined with Inhibitors (Trifluoperazine/Verapamil) of P-Glycoprotein in Patients with Advanced Renal Cell Carcinoma, Phase II

Research Committee(s)

Genitourinary Cancer

Activated

09-01-1992

Closed

09-01-1994

Closed

Phase

Accrual

47%

SWOG Clinical Trial Number

SWOG-9128

Phase I Trial of Doxorubicin, DTIC and Ifosfamide with Recombinant Granulocyte-Macrophage Colony Stimulating Factor/Peripheral Blood Progenitor Cell Infusion in Advanced Soft Tissue Sarcomas

Activated

09-01-1992

Closed

12-01-1994

Closed

Phase

Accrual

58%

SWOG Clinical Trial Number

SWOG-9148

A Phase II Study of Cisplatin Preceded By A 12-Hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) For Patients with Untreated, Extensive Stage Small Cell and Non-Small Cell Lung Carcinoma

Activated

09-01-1992

Closed

06-01-1995

Closed

Phase

Accrual

86%

Published

SWOG Clinical Trial Number

SWOG-9005

Double Blind Randomized Trial of the Anti-Progestational Agent Mifepristone In The Treatment of Unresectable Meningioma, Phase III

Research Committee(s)

Brain Cancer

Activated

08-15-1992

Closed

07-01-1998

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9143

A Phase II Study of Cisplatin Preceded by a 12-hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) for Patients with Untreated Malignant Mesothelioma

Activated

08-15-1992

Closed

09-15-1994

Closed

Phase

Accrual

57%

Published

SWOG Clinical Trial Number

SWOG-9150

Evaluation of Topotecan in Gastric Cancer, Phase II

Research Committee(s)

Gastrointestinal Cancer

Activated

07-15-1992

Closed

10-15-1993

Closed

Phase

Accrual

58%

Published

SWOG Clinical Trial Number

SWOG-8955

Treatment of Stage D, Hormone Refractory Carcinoma of the Prostate with 5/Fluorouracil and Roferon-A®, Phase II

Research Committee(s)

Genitourinary Cancer

Activated

06-15-1992

Closed

11-01-1993

Closed

Phase

Accrual

35%

SWOG Clinical Trial Number

SWOG-9147

Evaluation of Tamoxifen in Desmoid Tumors, Phase II

Activated

06-01-1992

Closed

08-01-1996

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9116

Evaluation of Piroxantrone in Disseminated Malignant Melanoma, Phase II

Activated

06-01-1992

Closed

10-01-1993

Closed

Phase

Accrual

62%

Published

SWOG Clinical Trial Number

SWOG-9124

Evaluation of Edatrexate (EDX) in Patients with Relapsed or Refractory Germ Cell Tumors, Phase II

Research Committee(s)

Genitourinary Cancer

Activated

06-01-1992

Closed

09-01-1996

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9032

A Controlled Trial of Cyclosporine As A Chemotherapy-Resistance Modifier in Blast Phase-Chronic Myelogenous Leukemia

Research Committee(s)

Leukemia

Activated

06-01-1992

Closed

03-01-1998